IMPORTANCE Persistent opioid use is currently a major health care crisis. There is a lack of knowledge regarding its prevalence and effect among patients undergoing cardiac surgery.
T he opioid epidemic is a leading public health concern in the United States. An estimated 2 million individuals in the United States experience opioid use disorder (OUD), accruing annual costs of approximately $78.5 billion.
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The prevalence of OUD and associated burden of mortality have increased at an alarming rate over the past 15 years. 4 ,5 Opioidrelated overdoses accounted for nearly 33 100 deaths in 2015 alone, half of which were associated with prescription opioids.
Prolonged opioid use has been associated with cardiovascular risk, although the mechanism of opioids in the pathogenesis of cardiovascular disease is unclear. A few reports have correlated coronary heart disease, myocardial infarction, poor post-myocardial infarction perfusion, and cardiovascular death with persistent opioid use.
6-8 The contribution of infectious endocarditis (IE) to mortality among the population of intravenous drugs users (IVDUs) is well established in this population, accounting for 5% to 10% of deaths. [9] [10] [11] Despite all this, data regarding the prevalence and outcomes of cardiovascular operations in this population are limited.
To our knowledge, most recent studies have focused on the negative outcomes from prescription opioid overdose and persistent use that occur postoperatively. [12] [13] [14] However, because preoperative persistent opioid use is a risk factor for postoperative overdose and because nonphysician/illicit sources (the third highest provider of opioids) may equally have a negative effect on surgical outcomes, it is important for the effects of preoperative opioid misuse to be investigated. 15, 16 Studies investigating the association of OUD with surgical outcomes are limited. In particular, data regarding the outcomes of cardiovascular operations in this population are restricted mainly to reports based on single-institution experiences only. 10, [17] [18] [19] [20] [21] As such, a population-based overview of surgical outcomes among patients with OUD after various cardiovascular operations has not been previously reported. Therefore, the aims of this study were to use data from a large national database to (1) characterize the population of cardiac surgery patients with OUD and (2) investigate the association of underlying OUD with outcomes and resource utilization after cardiovascular operations.
Methods

Data Source and Study Population
The Healthcare Cost and Utilization Project National Inpatient Sample (NIS) database (managed by the Agency for Healthcare Research and Quality) was queried from January 1998 through December 2013 for patients undergoing isolated coronary artery bypass graft (CABG), valve surgery, or aortic surgery or a combination of these using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and procedure codes. The NIS database is the largest all-payer inpatient discharge database, containing unweighted data from more than 7 million hospitalizations per year and weighted data from more than 35 million hospitalizations. Patients in this database represent a 20% stratified random sample of all discharges in a given year. Because the database contains publicly available deidentified data, this study did not require review from our institutional review board. Clinical Classifications Software procedure codes 44, 43, and 52 were used to identify patients undergoing CABG, valve surgery, and aortic surgery, respectively. 22 We defined a history of OUD with International Classification of Diseases, Ninth
Revision, Clinical Modification codes, previously described by Menendez et al. 23 This operative definition is consistent with that listed by the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition). 24, 25 Patients without these diagnoses were used as a control group. Pregnant patients and patients younger than 18 years or older than 100 years were also excluded.
Outcomes
Patient-level variables included age, sex, race/ethnicity, insurance status, income level, admission status, and discharge disposition. Patient race/ethnicity was previously classified by the NIS database, not by the authors, and was collected for the identification of possible disparities among racial/ethnic groups. Primary outcomes included mortality, complications, length of stay, hospital charges (ie, amount billed to hospitals for services, excluding professional fees), cost (ie, charges adjusted for inflation using a cost-to-charge ratio created by the Healthcare Cost and Utilization Project based on accounting reports from the US Centers of Medicare and Medicaid Services), and discharge outcomes. Complications included stroke, blood transfusion, wound infection, renal complication, cardiac complication, gastrointestinal tract complication, pulmonary embolism, deep vein thrombosis, pneumonia, mechanical ventilation, prolonged postoperative pain, and sepsis.
Statistical Analysis
Means with standard deviations and medians with standard errors were calculated for all continuous outcomes, while frequency counts and percentages were calculated for categorical outcomes. Appropriate statistical tests were used for continuous (t test) and categorical (χ 2 test) outcomes to compare unadjusted differences between patients with and without OUD. Propensity matching was conducted to balance covariables between patients with and without OUD to determine
Key Points
Question What are the associations of opioid use disorder (OUD) with outcomes of cardiovascular surgery?
Findings In this US nationwide cohort study of 5 718 552 cardiac surgery patients, compared with patients without OUD, there was no significant difference in mortality among patients with OUD, although they had a higher number of complications overall (67.6% vs 59.2%).
Meaning Cardiac surgery in patients with OUD is safe, but it is associated with higher complications and resource utilization. outcomes independent of confounding factors. Propensity scores (ie, the conditional probability of having OUD) were estimated for each patient using a multivariable regression model. Opioid use disorder was the dependent variable and patient demographic characteristics, payer status, comorbidities, hospital characteristics, and procedure type were the independent variables. We used a 1:1 greedy matching algorithm with a caliper of 0.2-fold the standard deviation of the linear propensity score. The balance of the covariables before and after matching were assessed using standardized differences between those with and without OUD (eFigure in the Supplement). 26 For all covariables, χ 2 tests were performed before matching, and McNemar tests were used in the matched sample. Comorbidities in the model described by Elixhauser et al 27 for administrative databases were used for propensity matching. A detailed list of all comorbidities used can be found in Table 1 . Although the Society of Thoracic Surgeons risk score has also been used for risk stratification, it was not the ideal model for this study since the very specific comorbidities it lists would not be readily available in a dischargelevel database such as the NIS database. After matching, we compared outcomes between patients with and without OUD using paired t tests for continuous outcomes (eg, costs and length of stay) and conditional logistic regression for categorical outcomes (eg, mortality and complications). All P values were 2-tailed, and P values less than .05 were considered statistically significant. All analyses were conducted using the SAS System for Unix version 9.2 (SAS Institute).
Results
Demographic and Patient Characteristics
A total of 5 718 552 patients undergoing CABG, valve surgery, or aortic surgery between 1998 and 2013 were available from the NIS database. Among these, 11 359 patients (0.2%) met the criteria of OUD for analysis. Patients with OUD were younger than patients without OUD, with a mean (SD) age of 48 (0.30) years vs 66 (0.05) years (P < .001). Figure 1A Distribution of procedure type is shown in Figure 1B . Compared with patients without OUD, patients with OUD were much more likely to undergo valve surgery (47 P < .001). Other patient-specific characteristics can be found in Table 1 .
Trends
Trends in case volume, adjusted mortality, and adjusted overall morbidity are shown in Figure 2 . From 1998 to 2013, the number of cardiac surgery patients with a history of OUD significantly increased 8-fold from 0.06% (262 of 437 641) of all annual cases to 0.54% (1425 of 263 930) (P < .001). Mortality rates did not significantly change from 1998 to 2013, but overall morbidity increased from 56% (146 of 262) to 74% (1050 of 1425) (P < .001). The median length of stay was significantly higher in patients with OUD, as was the median total cost. Patients with OUD were more likely to be discharged to a long-term skilled inpatient facility than to home (odds ratio [OR], 1.56; 95% CI, 1.47-1.72; P < .001).
Outcomes
Risk of mortality ( Figure 3 ) was increased among cardiac surgery patients with OUD who were black (OR, 1.71; 95% CI, 1.27-2.30; P = .02) or Hispanic (OR, 2.07; 95% CI, 1.46-2.93; P < .001). Arrhythmia (OR, 1.92; 95% CI, 1.51-2.43; P < .001), heart failure (OR, 1.83; 95% CI, 1.10-3.04; P = .02), coagulopathy (OR, 1.38; 95% CI, 1.05-1.80; P = .02), and endocarditis (OR, 2.04; 95% CI, 1.54-2.71; P < .001) also increased the likelihood of mortality in this group. Location in the West region was a significant predictor of mortality (OR, 2.76; 95% CI, 1.95-3.91; P < .001). Hospital volumes greater than 200 surgeries per year were protective against mortality (200-699 surgeries: OR, 0.65; 95% CI, 0.45-0.93; 700-1000 surgeries: OR, 0.65; 95% CI, 0.42-0.89). There were no mortalities for case volumes greater than 2000 cardiac surgeries per year. Patients with OUD were more often distributed in hospitals in the Northeast and West regions, and location in the West region was a significant predictor of mortality. This is consistent with geographical distribution of disproportionately high rates of opioid prescription and persistent opioid use on California's west coast. 31 Other reports also support our finding that cardiac surgery patients with OUD are in line with the general OUD population in age (younger) and sex (male).
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Most patients with OUD in our analysis underwent either CABG (42.7%) or valve surgery (47.5%). The association of CABG outcomes with opiate use has been studied by mainly single-center studies in the Middle East, where opium use is prominent because of rumored cardioprotective effects. In a historical cohort study of 110 patients addicted to opium over 1.5 years, Nemati et al 33 reported a significant increase in hemorrhage and blood transfusions after CABG, consistent with our findings. A prospective review of 56 opium-using patients conducted by Safaii and Kazemi 17 reported no difference in mortality and comparable complication rates (pulmonary complications, 14.2%; blood transfusions, 33.3%), but complications did not significantly differ between opium users and nonusers. It is important to note that the population studied differs from ours in that opium use in the Middle East may not directly translate to the opioid-type drugs used in the United States. Our sample size was also much larger because of our population-based approach. Although CABG and valve surgery were the most common procedures, we found that patients with OUD were less likely to undergo CABG than those without OUD despite evidence to suggest an increased risk of coronary and ischemic heart disease from persistent opioid use. [6] [7] [8] This may be attributed to the younger age group and significantly lower prevalence of other major cardiovascular risk factors (eg, hypertension, diabetes, peripheral vascular disease, and obesity) in our sample. Cardiac surgery patients with OUD were more likely to have valve surgery or aortic surgery compared with those without OUD. Infectious endocarditis in the population of IVDUs is a well-established complication and may contribute to the increased number of valve procedures. 9-11 A retrospective study of 29 IVDUs by Østerdal et al 21 reported that 69% of these patients used opioids (ie, heroin, buprenorphine, and methadone hydrochloride). Staphylococcus aureus (52%) and Enterococcus faecalis (17%) infections were the primary causative agents in those requiring valve surgery. A total of 33 valves or rings were implanted (most often aortic valves), with a 30-day mortality of 7%. Five patients underwent a concurrent aortic root replacement, which may also help explain the higher rate of aortic surgery in our cohort. A 2017 study 11 also used the NIS database to examine 809 patients with OUD undergoing valve surgery owing to infectious endocarditis and reported significantly higher rates of pulmonary embolism and prolonged length of stay, but in contrast with our results, they also reported increased postoperative pneumonia (OR, 1.4), pulmonary embolism (OR, 1.9), infectious complications (OR, 1.5), and sepsis (OR, 1.4). We conducted a post hoc analysis excluding endocarditis from our propensity matching (eTable 2 in the Supplement). As a result, rates of pneumonia, sepsis, and renal complications became significantly higher among patients with OUD. Hence, it appears that OUD-related infectious endocarditis is the driving factor behind these specific complications. Overall, complications were significantly higher in patients with OUD. We report higher rates of postoperative pulmonary embolism and blood transfusions. Heroin users are susceptible to ischemia from septic emboli secondary to infectious endocarditis. 34 A retrospective study 35 of deceased IVDUs using mainly opioids and benzodiazepenes from 1997 to 2013 showed a high incidence of pulmonary emboli (43.4%), vascular scarring (8.0%), pulmonary hypertension (10.2%), and right-sided pathology (5.4%). In addition, some users injected crushed prescription opioids in combination with other foreign substances, such as aspirin, caffeine, and talcum powder, which can directly embolize to form nonseptic emboli. Injection of opioid tablets intended for oral use may also contribute to the increase in blood transfusions. Just as in our study population, increased rates of anemia have been reported among IVDUs, although there is no consensus regarding the etiology. [37] [38] [39] Microangiopathic hemolytic anemia generally occurs where red blood cells directly contact diseased blood vessels, especially in cases of inflammation, emboli, and pulmonary hypertension. 40 Since these risk factors are all reported among IVDUs, it is possible that IVDUs are predisposed to microangiopathic hemolytic anemia and, hence, increased postoperative blood transfusions. A thrombotic thrombocytopenic purpura-like anemia has in fact been reported in cases of persistent intravenous opioid use. 41 We found that patients with OUD had significantly higher rates of mechanical ventilation. Respiratory compromise may be related to predisposition of IVDUs to pulmonary hypertension.
However, respiratory depression is also a pronounced characteristic of opioid overdose. 42, 43 In the general patient population, incidence of respiratory depression from postoperative narcosis varies from 0.3% to 37%. 44 Given the findings of our study, we suspect that OUD status increases the risk of opioid overdoserelated respiratory depression. Although we report no significant difference in respiratory failure, this is most likely because of the way these complications are coded. It is likely that patients were either coded for postoperative mechanical ventilation or respiratory failure but not both. Opioid tolerance and hyperalgesia are common among persistent opioid users, supported by our finding that these patients also had higher rates of prolonged postoperative pain. 44, 45 This poses significant implications for perioperative pain management. Perioperative analgesia in opioid-dependent patients should effectively treat pain while minimizing the risks of postoperative addiction or withdrawal. International Association for the Study of Pain 2017 guidelines recommend that analgesia should be titrated to effect, ideally by a multimodal approach that makes use of regional, adjuvant, and nonopioid methods in either the preoperative (anesthesia) or postoperative setting.
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N-methyl-D-aspartate antagonists can be successful in targeting hyperalgesia, with reports indicating as much as 50% reduction in postoperative pain and a decrease in patient-controlled opioid consumption from a single methadone bolus of 0.2 mg/kg before surgical incision. 47 Many protocols for opioid-dependent patients have also been developed with success using low-dose subanesthetic ketamine infusions postoperatively, usually at 60 to 120 μg/kg/h over 4 hours. 47 The multimodal approach should also address the psychological component of pain, since our results show high rates of depression among patients with OUD.
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Limitations
Although our study provides insight into the trends and outcomes of cardiac surgery in patients with OUD, there are inherent limitations. The NIS database is an administrative database based on billing data and, as such, only provides discharge-level information. Specific clinical data, such as quantification of persistent opioid use, postoperative pain management, or operation-specific factors, are not available. This also limits our ability to surmise the true etiology of complications associated with OUD. Because the database relies on a set of clinical diagnosis codes, it is possible that OUD is underreported and that the definitions of opioid dependence or persistent opioid use are not consistent from hospital to hospital. Despite these limitations, the NIS database is ideal for the objective of our study: to investigate trends and hospitallevel outcomes on a national scale in a rare subset of patients through access to data on millions of operations. Our study provides an overall clinical picture of outcomes that can be anticipated for the OUD population. The presence of OUD preoperatively is not currently a component of standard preoperative risk assessment. Our findings suggest that there may be value in incorporating OUD status into assessment algorithms (eg, the Society of Thoracic Surgeons risk calculator) to give surgeons and clinicians a clearer picture of operative outcomes. Future work examining specific operative factors and clinical end points will allow for more thorough guide- 
Conclusions
In conclusion, preoperative OUD in cardiac surgery patients does not increase mortality but confers an increased burden of morbidity and resource utilization. Trends in patient volume and morbidity reported in our study suggest that cardiac surgeons are likely to encounter this population of patients more often now than in the past and should be prepared to adequately manage the perioperative factors specific to them. In urgent situations, patients need not be denied cardiac surgery because of their OUD status, although close postoperative monitoring is suggested. 
